Positive News SentimentPositive NewsNYSE:STVN Stevanato Group (STVN) Stock Forecast, Price & News €26.60 +0.01 (+0.04%) (As of 03:09 PM ET) Add Compare Share Share Today's Range€25.89▼€26.6450-Day Range€23.02▼€28.8952-Week Range€13.71▼€29.67Volume234,638 shsAverage Volume282,755 shsMarket Capitalization$7.86 billionP/E Ratio46.67Dividend YieldN/APrice Target€29.60 ProfileProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Stevanato Group MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside12.5% Upside€29.60 Price TargetShort InterestHealthy1.79% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.52Based on 2 Articles This WeekInsider TradingN/AProj. Earnings Growth16.13%From €0.62 to €0.72 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.20 out of 5 starsMedical Sector414th out of 1,006 stocksSurgical & Medical Instruments Industry44th out of 104 stocks 2.5 Analyst's Opinion Consensus RatingStevanato Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of €29.60, Stevanato Group has a forecasted upside of 12.5% from its current price of €26.32.Amount of Analyst CoverageStevanato Group has only been the subject of 4 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.79% of the float of Stevanato Group has been sold short.Short Interest Ratio / Days to CoverStevanato Group has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Stevanato Group has recently increased by 16.80%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldStevanato Group does not currently pay a dividend.Dividend GrowthStevanato Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for STVN. Previous Next 3.1 News and Social Media Coverage News SentimentStevanato Group has a news sentiment score of 1.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Stevanato Group this week, compared to 2 articles on an average week.MarketBeat Follows1 people have added Stevanato Group to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Stevanato Group insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 10.27% of the stock of Stevanato Group is held by institutions. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Stevanato Group are expected to grow by 16.13% in the coming year, from €0.62 to €0.72 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Stevanato Group is 46.18, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 124.70.Price to Earnings Ratio vs. SectorThe P/E ratio of Stevanato Group is 46.18, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 96.44.Price to Earnings Growth RatioStevanato Group has a PEG Ratio of 2.05. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioStevanato Group has a P/B Ratio of 7.04. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Stevanato Group (NYSE:STVN) StockStevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.Read More Receive STVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stevanato Group and its competitors with MarketBeat's FREE daily newsletter. Email Address STVN Stock News HeadlinesMay 25, 2023 | finance.yahoo.comShould You Invest in Stevanato Group S.p.A. (STVN)?May 10, 2023 | americanbankingnews.comStevanato Group S.p.A. (NYSE:STVN) to Post Q2 2023 Earnings of $0.15 Per Share, William Blair ForecastsMay 31, 2023 | Edge On The Street (Ad)Soaring EV Industry Keeps Investor Focus on LithiumThe need for lithium keeps going up, up, up with the mass adoption of electric vehicles. The lithium demand for EV batteries alone is now double the rate of lithium production.May 10, 2023 | americanbankingnews.comBrokers Offer Predictions for Stevanato Group S.p.A.'s Q3 2023 Earnings (NYSE:STVN)May 9, 2023 | americanbankingnews.comWells Fargo & Company Increases Stevanato Group (NYSE:STVN) Price Target to $30.00May 9, 2023 | americanbankingnews.comStevanato Group (NYSE:STVN) Price Target Raised to $29.00 at UBS GroupMay 6, 2023 | msn.comCitigroup Maintains Stevanato Group (STVN) Buy RecommendationMay 6, 2023 | americanbankingnews.comStevanato Group (NYSE:STVN) Shares Gap Down to $27.78May 31, 2023 | Edge On The Street (Ad)The Ignored EV Story Few Investors Know AboutLithium may grab all the headlines, but the average electric vehicle requires 146 pounds of the mineral graphite. With no producing graphite mines in North America, the U.S. government is desperate for more domestic sources of the metal to feed the EV battery supply chain.May 6, 2023 | finance.yahoo.comStevanato Group S.p.A. (NYSE:STVN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$31.50May 5, 2023 | msn.comWells Fargo Maintains Stevanato Group (STVN) Overweight RecommendationMay 5, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Karuna Therapeutics (KRTX), Stevanato Group (STVN)May 5, 2023 | markets.businessinsider.comCitigroup Keeps Their Buy Rating on Stevanato Group (STVN)May 5, 2023 | msn.comKeybanc Maintains Stevanato Group (STVN) Overweight RecommendationMay 4, 2023 | finance.yahoo.comStevanato Group (STVN) Q1 Earnings Lag EstimatesMay 4, 2023 | finance.yahoo.comAs Covid Wanes, Maker Of Glass Vials, Other Medical Products Misses EstimatesMay 4, 2023 | finanznachrichten.deStevanato Group S.p.A.: Stevanato Group Reports First Quarter 2023 Financial ResultsMay 4, 2023 | msn.comStevanato Group Non-GAAP EPS of €0.11, revenue of €238MMay 4, 2023 | finance.yahoo.comStevanato Group Reports First Quarter 2023 Financial ResultsMay 3, 2023 | americanbankingnews.comStevanato Group (STVN) Set to Announce Earnings on ThursdayMay 3, 2023 | americanbankingnews.comHead to Head Analysis: enVVeno Medical (NASDAQ:NVNO) and Stevanato Group (NYSE:STVN)May 2, 2023 | finance.yahoo.comStevanato Group to Present at BofA Securities Healthcare ConferenceApril 18, 2023 | finance.yahoo.comStevanato Group S.p.A. (STVN) Hit a 52 Week High, Can the Run Continue?April 17, 2023 | finance.yahoo.comStevanato Group to Report First Quarter 2023 Financial Results on May 4, 2023April 5, 2023 | americanbankingnews.comComparing Stevanato Group (STVN) and The CompetitionMarch 31, 2023 | finance.yahoo.comDoes Stevanato Group S.p.A. (NYSE:STVN) Create Value For Shareholders?March 26, 2023 | americanbankingnews.comHead-To-Head Review: Stevanato Group (STVN) vs. Its PeersSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive STVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stevanato Group and its competitors with MarketBeat's FREE daily newsletter. Email Address STVN Company Calendar Last Earnings3/02/2023Today5/31/2023Next Earnings (Estimated)8/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNYSE:STVN CUSIPN/A CIK1849853 Webwww.stevanatogroup.com Phone39049931811FaxN/AEmployees5,260Year FoundedN/APrice Target and Rating Average Stock Price Forecast€29.60 High Stock Price Forecast€32.00 Low Stock Price Forecast€27.00 Forecasted Upside/Downside+11.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)€0.57 Trailing P/E Ratio46.65 Forward P/E Ratio42.89 P/E Growth2.05Net Income$150.51 million Net Margins14.17% Pretax Margin18.63% Return on Equity15.15% Return on Assets9.00% Debt Debt-to-Equity Ratio0.14 Current Ratio1.61 Quick Ratio1.14 Sales & Book Value Annual Sales$1.04 billion Price / Sales7.58 Cash Flow€0.75 per share Price / Cash Flow35.24 Book Value€3.74 per share Price / Book7.11Miscellaneous Outstanding Shares295,540,000Free FloatN/AMarket Cap$7.86 billion OptionableNot Optionable Beta0.74 Key ExecutivesMr. Franco Stevanato (Age 50)Exec. Chairman Mr. Franco Moro (Age 60)CEO, COO & Director Mr. Marco Dal Lago (Age 51)Chief Financial Officer Mr. Paolo Patri (Age 53)Chief Technology Officer Ms. Lisa MilesSr. VP of Investor RelationsMr. Mauro Stocchi (Age 57)Chief Bus. Officer Mr. Riccardo ButtaPres of AmericasMore ExecutivesKey CompetitorsNovoCureNASDAQ:NVCRInspire Medical SystemsNYSE:INSPShockwave MedicalNASDAQ:SWAVGlobus MedicalNYSE:GMEDTeleflexNYSE:TFXView All CompetitorsInstitutional OwnershipAmeriprise Financial Inc.Sold 517,839 shares on 5/22/2023Ownership: 0.507%JPMorgan Chase & Co.Bought 27,676 shares on 5/18/2023Ownership: 0.086%Thrivent Financial for LutheransBought 1,752,188 shares on 5/17/2023Ownership: 0.593%Silvercrest Asset Management Group LLCSold 4,040 shares on 5/16/2023Ownership: 0.154%Snowden Capital Advisors LLCSold 3,625 shares on 5/16/2023Ownership: 0.009%View All Institutional Transactions STVN Stock - Frequently Asked Questions Should I buy or sell Stevanato Group stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Stevanato Group in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" STVN shares. View STVN analyst ratings or view top-rated stocks. What is Stevanato Group's stock price forecast for 2023? 4 Wall Street research analysts have issued 12 month price targets for Stevanato Group's shares. Their STVN share price forecasts range from €27.00 to €32.00. On average, they anticipate the company's stock price to reach €29.60 in the next twelve months. This suggests a possible upside of 11.3% from the stock's current price. View analysts price targets for STVN or view top-rated stocks among Wall Street analysts. How have STVN shares performed in 2023? Stevanato Group's stock was trading at €17.97 at the start of the year. Since then, STVN shares have increased by 48.0% and is now trading at €26.59. View the best growth stocks for 2023 here. Are investors shorting Stevanato Group? Stevanato Group saw a decline in short interest in April. As of April 30th, there was short interest totaling 522,600 shares, a decline of 19.0% from the April 15th total of 645,100 shares. Based on an average trading volume of 274,700 shares, the days-to-cover ratio is presently 1.9 days. Approximately 1.5% of the company's stock are sold short. View Stevanato Group's Short Interest. When is Stevanato Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023. View our STVN earnings forecast. How were Stevanato Group's earnings last quarter? Stevanato Group S.p.A. (NYSE:STVN) posted its earnings results on Thursday, March, 2nd. The company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.16 by $0.03. The firm earned $292.10 million during the quarter, compared to the consensus estimate of $271.89 million. Stevanato Group had a trailing twelve-month return on equity of 15.15% and a net margin of 14.17%. The firm's quarterly revenue was up 25.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.15 EPS. How often does Stevanato Group pay dividends? What is the dividend yield for Stevanato Group? Stevanato Group declared a -- dividend on Wednesday, June 8th. Investors of record on Tuesday, June 14th will be given a dividend of 0.051 per share on Wednesday, July 13th. This represents a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, June 13th. Read our dividend analysis for STVN. What ETFs hold Stevanato Group's stock? ETFs with the largest weight of Stevanato Group (NYSE:STVN) stock in their portfolio include First Trust IPOX Europe Equity Opportunities ETF (FPXE), Goldman Sachs Future Health Care Equity ETF (GDOC), First Trust International IPO ETF (FPXI), SPDR S&P Kensho New Economies Composite ETF (KOMP), iShares Biotechnology ETF (IBB), What guidance has Stevanato Group issued on next quarter's earnings? Stevanato Group issued an update on its FY 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share guidance of $0.62-$0.67 for the period, compared to the consensus estimate of $0.67. The company issued revenue guidance of $1.16 billion-$1.20 billion, compared to the consensus revenue estimate of $1.22 billion. When did Stevanato Group IPO? (STVN) raised $720 million in an IPO on Friday, July 16th 2021. The company issued 32,000,000 shares at a price of $21.00-$24.00 per share. What is Stevanato Group's stock symbol? Stevanato Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "STVN." Who are Stevanato Group's major shareholders? Stevanato Group's stock is owned by a number of institutional and retail investors. Top institutional investors include Conestoga Capital Advisors LLC (1.20%), Copeland Capital Management LLC (0.72%), Thrivent Financial for Lutherans (0.59%), Ameriprise Financial Inc. (0.51%), Wellington Management Group LLP (0.36%) and Nicholas Company Inc. (0.29%). How do I buy shares of Stevanato Group? Shares of STVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Stevanato Group's stock price today? One share of STVN stock can currently be purchased for approximately €26.59. How much money does Stevanato Group make? Stevanato Group (NYSE:STVN) has a market capitalization of $7.86 billion and generates $1.04 billion in revenue each year. The company earns $150.51 million in net income (profit) each year or €0.57 on an earnings per share basis. How many employees does Stevanato Group have? The company employs 5,260 workers across the globe. How can I contact Stevanato Group? Stevanato Group's mailing address is PIOMBINO DESE (PD) VIA MOLINELLA 17, PADUA L6, 35017. The official website for the company is www.stevanatogroup.com. The company can be reached via phone at 39049931811 or via email at ir@stevanatogroup.com. This page (NYSE:STVN) was last updated on 5/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stevanato Group S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.